We are live on ! Find out more
WA

Waddell & Associates Portfolio holdings

AUM $2.02B
1-Year Est. Return 36.49%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+36.49%
3 Year Est. Return
+193.58%
5 Year Est. Return
+188.65%
10 Year Est. Return
AUM
$597M
AUM Growth
+$80.5M
Cap. Flow
+$34.3M
Cap. Flow %
5.74%
Top 10 Hldgs %
66.16%
Holding
157
New
17
Increased
79
Reduced
31
Closed
14
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACWI icon
26
iShares MSCI ACWI ETF
ACWI
$33.4B
$2.43M 0.41%
28,636
CVX icon
27
Chevron
CVX
$366B
$2.23M 0.37%
12,447
+62
+0.5% +$10.8K
LLY icon
28
Eli Lilly
LLY
$1.06T
$2.21M 0.37%
6,054
-4
-0.1% -$1.42K
TFC icon
29
Truist Financial
TFC
$64B
$2.11M 0.35%
49,038
+253
+0.5% +$11.1K
XOM icon
30
ExxonMobil
XOM
$634B
$1.98M 0.33%
17,915
-44
-0.2% -$4.71K
DFAE icon
31
Dimensional Emerging Core Equity Market ETF
DFAE
$9.7B
$1.96M 0.33%
89,420
+61,720
+223% +$1.31M
VOO icon
32
Vanguard S&P 500 ETF
VOO
$1.03T
$1.89M 0.32%
5,393
+730
+16% +$258K
PFE icon
33
Pfizer
PFE
$153B
$1.79M 0.3%
34,984
+329
+0.9% +$15.8K
KO icon
34
Coca-Cola
KO
$375B
$1.78M 0.3%
28,055
+1,013
+4% +$61.2K
JNJ icon
35
Johnson & Johnson
JNJ
$625B
$1.66M 0.28%
9,372
+122
+1% +$21.1K
PG icon
36
Procter & Gamble
PG
$339B
$1.58M 0.26%
10,396
+333
+3% +$46.7K
JPM icon
37
JPMorgan Chase
JPM
$950B
$1.43M 0.24%
10,668
+320
+3% +$40.5K
BMY icon
38
Bristol-Myers Squibb
BMY
$132B
$1.33M 0.22%
18,494
+93
+0.5% +$7.01K
QQQE icon
39
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.41B
$1.28M 0.22%
+20,114
New +$1.29M
AFL icon
40
Aflac
AFL
$62.6B
$1.23M 0.21%
17,103
+94
+0.6% +$6.29K
CSCO icon
41
Cisco
CSCO
$479B
$1.17M 0.2%
24,527
+213
+0.9% +$9.7K
IBM icon
42
IBM
IBM
$224B
$1.15M 0.19%
8,184
-130
-2% -$17.9K
CCOR icon
43
Core Alternative Capital
CCOR
$28M
$1.12M 0.19%
35,490
GLD icon
44
SPDR Gold Trust
GLD
$142B
$1.03M 0.17%
6,060
-200
-3% -$32.2K
ABBV icon
45
AbbVie
ABBV
$435B
$1.01M 0.17%
6,245
+620
+11% +$95.1K
WST icon
46
West Pharmaceutical
WST
$24.9B
$918K 0.15%
3,900
FHN icon
47
First Horizon
FHN
$12.1B
$900K 0.15%
36,722
-2,902
-7% -$70.3K
EEM icon
48
iShares MSCI Emerging Markets ETF
EEM
$30B
$898K 0.15%
23,684
+6,980
+42% +$258K
EW icon
49
Edwards Lifesciences
EW
$51.7B
$876K 0.15%
11,738
UNH icon
50
UnitedHealth
UNH
$370B
$858K 0.14%
1,617
+572
+55% +$303K

Similar funds

Waddell & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Waddell & Associates held 157 positions worth $597M, up 16% from $517M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Waddell & Associates deployed $34.3M of net new capital in Q4 2022, opening 17 new positions and adding to 79 existing holdings. Its largest new stake was State Street SPDR S&P Emerging Markets Small Cap ETF: 534,068 shares worth $26.1M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total World Stock ETF, an estimated $20.7M trimmed.

  • Waddell & Associates's largest Q4 2022 buy was State Street SPDR S&P Emerging Markets Small Cap ETF: 534,068 shares worth $26.1M.
  • Waddell & Associates added most to iShares International Small Cap Equity Factor ETF in Q4 2022, an estimated $10.8M increase.
  • Waddell & Associates's biggest Q4 2022 reduction was Vanguard Total World Stock ETF, cutting an estimated $20.7M.
  • Waddell & Associates fully exited WisdomTree Emerging Markets SmallCap Dividend Fund in Q4 2022, selling an estimated $23.4M.
  • Waddell & Associates's ten largest holdings make up 66% of its $597M portfolio in Q4 2022.
  • Waddell & Associates opened 17 new positions and closed 14 in Q4 2022.
  • Waddell & Associates's portfolio value rose 16% quarter-over-quarter to $597M.

Based on Waddell & Associates's 13F filing for Q4 2022, filed 10 Feb 2023.